BRAF-V600E Immunohistochemistry in a Large Series of Low Grade Glial and Glial-Neuronal Tumors of the Central Nervous System

被引:0
|
作者
Breton, Quentin [1 ]
Plouhinec, Helene [1 ]
Prunier-Mirebeau, Delphine [1 ]
Boisselier, Blandine [1 ]
Michalak, Sophie [1 ]
Menei, Philippe [1 ]
Rousseau, Audrey [1 ]
机构
[1] Univ Hosp Angers, Angers, France
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1714
引用
收藏
页码:429A / 429A
页数:1
相关论文
共 39 条
  • [31] Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification
    Gierke, Midea
    Sperveslage, Jan
    Schwab, David
    Beschorner, Rudi
    Ebinger, Martin
    Schuhmann, Martin U.
    Schittenhelm, Jens
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 89 - 100
  • [32] MR IMAGING OF PEDIATRIC LOW-GRADE GLIOMAS: PRETHERAPEUTIC DIFFERENTIATION OF BRAF V600E MUTATION, BRAF-FUSED AND WILD-TYPE TUMORS IN PATIENTS WITHOUT NEUROFIBROMATOSIS-1
    Trasolini, Andrew
    Erker, Craig
    Cheng, Sylvia
    Crowell, Cameron
    McFadden, Kathryn
    Moineddin, Rahim
    Sargent, Michael
    Mata-Mbemba, Daddy
    NEURO-ONCOLOGY, 2022, 24 : 88 - 89
  • [33] Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
    Genevieve Schindler
    David Capper
    Jochen Meyer
    Wibke Janzarik
    Heymut Omran
    Christel Herold-Mende
    Kirsten Schmieder
    Pieter Wesseling
    Christian Mawrin
    Martin Hasselblatt
    David N. Louis
    Andrey Korshunov
    Stefan Pfister
    Christian Hartmann
    Werner Paulus
    Guido Reifenberger
    Andreas von Deimling
    Acta Neuropathologica, 2011, 121 : 397 - 405
  • [34] Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
    Schindler, Genevieve
    Capper, David
    Meyer, Jochen
    Janzarik, Wibke
    Omran, Heymut
    Herold-Mende, Christel
    Schmieder, Kirsten
    Wesseling, Pieter
    Mawrin, Christian
    Hasselblatt, Martin
    Louis, David N.
    Korshunov, Andrey
    Pfister, Stefan
    Hartmann, Christian
    Paulus, Werner
    Reifenberger, Guido
    von Deimling, Andreas
    ACTA NEUROPATHOLOGICA, 2011, 121 (03) : 397 - 405
  • [35] BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease
    J. Picarsic
    T. Pysher
    H. Zhou
    M. Fluchel
    T. Pettit
    M. Whitehead
    L. F. Surrey
    B. Harding
    G. Goldstein
    Y. Fellig
    M. Weintraub
    B. C. Mobley
    P. M. Sharples
    M. L. Sulis
    E. L. Diamond
    R. Jaffe
    K. Shekdar
    M. Santi
    Acta Neuropathologica Communications, 7
  • [36] BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease
    Picarsic, J.
    Pysher, T.
    Zhou, H.
    Fluchel, M.
    Pettit, T.
    Whitehead, M.
    Surrey, L. F.
    Harding, B.
    Goldstein, G.
    Fellig, Y.
    Weintraub, M.
    Mobley, B. C.
    Sharples, P. M.
    Sulis, M. L.
    Diamond, E. L.
    Jaffe, R.
    Shekdar, K.
    Santi, M.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [37] Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice
    Xu, PT
    Schmechel, D
    RothrockChristian, T
    Burkhart, DS
    Qiu, HL
    Popko, B
    Sullivan, P
    Maeda, N
    Saunders, AM
    Roses, AD
    Gilbert, JR
    NEUROBIOLOGY OF DISEASE, 1996, 3 (03) : 229 - 245
  • [38] Phase 1 trial of MEK1 inhibitor E6201 plus dabrafenib in patients (pts) with BRAF V600-mutated metastatic melanoma (MM) with central nervous system (CNS) metastases (mets)
    Seetharam, Mahesh
    Dronca, Roxana
    Dudek, Arkadiusz Z.
    Nelson, Garth
    Block, Matthew
    Starling, Skylar
    Baskin, Amber
    Bradshaw, Renee
    Nelson, Courtney
    Andrews, Kylee
    Birgin, Alisha
    Watson, Cristina
    Yan, Yiyi
    Mahadevan, Daruka
    Markovic, Svetomir
    Myers, Tom
    Paradiso, Linda
    Babiker, Hani
    CANCER RESEARCH, 2024, 84 (07)
  • [39] Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST).
    Kieran, Mark W.
    Hargrave, Darren R.
    Cohen, Kenneth J.
    Aerts, Isabelle
    Dunkel, Ira J.
    Hummel, Trent Ryan
    Jimenez, Irene
    Pearson, Andrew D. J.
    Pratilas, Christine A.
    Whitlock, James
    Bouffet, Eric
    Shen, Wei-Ping Violet
    Broniscer, Alberto
    Bertozzi, Anne-Isabelle
    Sandberg, Joan L.
    Florance, Allison M.
    Suttle, Benjamin B.
    Haney, Pat
    Russo, Mark W.
    Geoerger, Birgit
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)